GBM: Microwave News Article Archive (2004 - )
It's been a year since the Philips paper was published. This is the first discussion of its implications. See our report published last March.
Frank de Vocht confirms that GBM is rising in the U.K. but argues that it’s “unlikely” that RF from cell phones is responsible.
Supplementing chemotherapy with 200 kHz E-fields increased progression-free survival (by 2.7 months to 6.7 months) and overall survival (by 4.9 months to 20.9 months) in patients with newly diagnosed glioblastoma. Both are statistically significant improvements.
The National Toxicology Program (NTP) will release the “complete results” of its $25 million project on cell phone cancer risks early next year, according to a statement posted on its Web site yesterday.
“The complete results from all the rats and mice studies will be available for peer review and public comment by early 2018,” the NTP states. The animals were exposed to GSM or CDMA radiation for two years before they were sacrificed...
The incidence of glioblastoma multiforme (GBM), the most virulent and deadly type of brain cancer, is going up in the U.K., while the incidence there of other types of malignant brain tumors are declining, according to some newly published raw data.
Take a look at the two plots below and the trends are immediately apparent.
The incidence rates are not corrected for age, or...
Novocure’s 200 kHz signals kept 43% of GBM patients alive compared to 30% on the standard treatment.
“Results from the present study on the use of mobile phones for ≥3 hours a day show a consistent pattern of increased risk for the mutant type of p53 gene expression in the peripheral zone of the glioblastoma, and that this increase was significantly correlated with shorter overall survival time. The risk was not higher for ipsilateral exposure.” From a German-Iranian team. Open access.